Page last updated: 2024-08-24

thiazolyl blue and Epstein-Barr Virus Infections

thiazolyl blue has been researched along with Epstein-Barr Virus Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Donovan, J; Huang, D; Li, JH; Liu, FF; Weinrib, L	1

Other Studies

1 other study(ies) available for thiazolyl blue and Epstein-Barr Virus Infections

Article	Year
Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma. Cancer gene therapy, 2001, Volume: 8, Issue:5 Topics: Adenoviridae; Antineoplastic Agents; beta-Galactosidase; Blotting, Western; Cell Survival; Cisplatin; Combined Modality Therapy; Epstein-Barr Virus Infections; Gene Expression; Genetic Therapy; Genetic Vectors; Herpesvirus 4, Human; Humans; Nasopharyngeal Neoplasms; Tetrazolium Salts; Thiazoles; Transfection; Tumor Suppressor Protein p53	2001

Article

Year

Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.

Cancer gene therapy, 2001, Volume: 8, Issue:5

Topics: Adenoviridae; Antineoplastic Agents; beta-Galactosidase; Blotting, Western; Cell Survival; Cisplatin; Combined Modality Therapy; Epstein-Barr Virus Infections; Gene Expression; Genetic Therapy; Genetic Vectors; Herpesvirus 4, Human; Humans; Nasopharyngeal Neoplasms; Tetrazolium Salts; Thiazoles; Transfection; Tumor Suppressor Protein p53

2001